2B7D

iShares S&P 500 Consumer Staples Sector UCITS Acc

ETFs & Funds · EUR · XETRA

2B7DETFT212

Price

€8.694

-1.14%

Cap

Earnings

30d Trend

+0.1%

2B7D
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

17% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level30
Momentum57
Technical49
Fund Quality68
Cost Efficiency69

Raw weighted: 63×Macro 0.99 (1%)=62

RISK

30/100
90d Volatility
17.1%Low
ATR %
1.5%Low daily moves
Max Drawdown (1Y)
-16.8%Normal

MOMENTUM

57/100
12-1M Momentum
+2.5%Uptrend
6-1M Momentum
+7.2%Positive
1M Return
+1.3%Stable

TECHNICAL

49/100
RSI (14)
51.3Neutral
Price vs SMA200
+5.6%Bullish trend
MACD
-0.02Bearish momentum
Bollinger Band
50%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.066Noisy/choppy

FUND QUALITY

68/100
Replication
PhysicalHolds actual assets
Holdings
33 positionsConcentrated
Domicile
Ireland (tax-efficient)15% US withholding tax
Yield
1.77% (Accumulating)Moderate

COST EFFICIENCY

69/100
Expense Ratio
0.30%Low cost
Fund Size (AUM)
$3.5BMid-size
Tracking Difference
-0.06%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months62
1-5+ years64

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate iShares S&P 500 Consumer Staples Sector UCITS Acc at 62/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 70/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+1.3%

3 MONTHS

-3.0%

12 MONTHS

+3.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Cost Efficiency (69) are the primary strengths. Historical volatility is normal at 17%. I classify this as a defensive holding — low volatility and high business quality provide portfolio ballast.

defensiveScore: 62/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.